← Eichor
Study identifier: NCT06950385 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Condition: Familial Adenomatous Polyposis (FAP)  ·  Sponsor: Rapamycin Holdings Inc.

PhasePhase 3
Planned participants168
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main goal of this clinical trial is to learn if the drug eRapa works to slow down the progression of disease in patients diagnosed with Familial Adenomatous Polyposis (FAP). Researchers will compare eRapa to Placebo. The questions to be answered by this trial are: * Does taking eRapa help to slow down the progression of the disease in patients with FAP? * Is eRapa a safe treatment for patients diagnosed with FAP? * What is the effect of eRapa on the number of polyps found in GI tract of patients diagnosed with FAP? * How does treatment with eRapa affect a patient's quality of life? Participants will: * Take eRapa or placebo once per day every other week until disease progresses (gets worse), stops taking part in the trial or dies. * Visit the clinic once every 3 months for check ups and tests. * Have an endoscopy at the start of the trial and then every 6 months to check on whether the disease is getting better or worse.

This description comes directly from the study's public registry record.

Talk to the study team

Vice President Clinical Operations  ·  XXX-XXX-XXXX  ·  jim.kostka@biodexapharma.com

Always discuss trial participation with your own doctor first.

Locations (29)

City of HopeArcadia, California, United StatesRecruiting
Yale Cancer CenterNew Haven, Connecticut, United StatesRecruiting
Georgetown UniversityWashington D.C., District of Columbia, United StatesRecruiting
Digestive & Liver Center of FloridaOrlando, Florida, United StatesRecruiting
Cleveland Clinic FloridaWeston, Florida, United StatesRecruiting
University of ChicagoChicago, Illinois, United StatesRecruiting
University of Kansas Medical CenterKansas City, Kansas, United StatesRecruiting
Johns Hopkins UniversityBaltimore, Maryland, United StatesRecruiting
Dana Farber Cancer InstituteBoston, Massachusetts, United StatesRecruiting
University of MichiganAnn Arbor, Michigan, United StatesRecruiting
Department of Surgery, Section of Colon Rectal and SurgerySt Louis, Missouri, United StatesRecruiting
Cleveland ClinicCleveland, Ohio, United StatesRecruiting

+ 17 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06950385